title: Tumor markers in prostate cancer I: blood-based markers.
abstract: The introduction of total prostate specific antigen (total PSA) testing in blood has revolutionized the detection and management of men with prostate cancer (PCa). The objective of this review was to discuss the challenges of PCa biomarker research, definition of the type of PCa biomarkers, the statistical considerations for biomarker discovery and validation, and to review the literature regarding total PSA velocity and novel blood-based biomarkers.
  
  
  METHODS
  An English-language literature review of the Medline database (1990 to August 2010) of published data on blood-based biomarkers and PCa was undertaken.
  
  
  RESULTS
  The inherent biological variability of total PSA levels affects the interpretation of any single result. Men who will eventually develop PCa have increased total PSA levels years or decades before the cancer is diagnosed. Total PSA velocity improves predictiveness of total PSA only marginally, limiting its value for PCa screening and prognostication. The combination of PSA molecular forms and other biomarkers improve PCa detection substantially. Several novel blood-based biomarkers such as human glandular kallikrein 2 (hK2), urokinase plasminogen activator (uPA) and its receptor (uPAR), transforming growth factor-beta 1 (TGF-β1); interleukin-6 (IL-6) and its receptor (IL-6R) may help PCa diagnosis, staging, prognostication, and monitoring. Panels of biomarkers that capture the biologic potential of PCa are in the process of being validated for PCa prognostication.
  
  
  CONCLUSIONS
  PSA is a strong prognostic marker for long-term risk of clinically relevant cancer. However, there is a need for novel biomarkers that aid clinical decision making about biopsy and initial treatment. There is no doubt that progress will continue based on the integrated collaboration of researchers, clinicians and biomedical firms.
authors: Department of Urology and Division of Medical Oncology, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY, USA.
authors: Shahrokh F
authors: SF
authors: Shariat
authors: Axel
authors: A
authors: Semjonow
authors: Hans
authors: H
authors: Lilja
authors: Caroline
authors: C
authors: Savage
authors: Andrew J
authors: AJ
authors: Vickers
authors: Anders
authors: A
authors: Bjartell
references: Urology. 2002 Jun;59(6):797-802
references: 12031356
references: Biochem Soc Trans. 2002 Apr;30(2):207-10
references: 12023852
references: J Clin Oncol. 2009 Sep 10;27(26):4300-5
references: 19636023
references: J Urol. 2004 Sep;172(3):900-4
references: 15310993
references: J Urol. 1999 Dec;162(6):2029-34; discussion 2034-5
references: 10569562
references: Cancer. 2010 Jun 1;116(11):2612-20
references: 20336781
references: Urology. 1996 Jan;47(1):59-66
references: 8560664
references: J Urol. 2007 Oct;178(4 Pt 1):1229-36; discussion 1236-7
references: 17698116
references: JAMA. 1998 May 20;279(19):1542-7
references: 9605898
references: Am Stat. 2008;62(4):314-320
references: 19132141
references: BMC Med Inform Decis Mak. 2008 Nov 26;8:53
references: 19036144
references: Urology. 2006 Feb;67(2):316-20
references: 16442597
references: Cancer. 2008 Sep 1;113(5):966-74
references: 18661513
references: Prostate. 2009 Jun 1;69(8):886-94
references: 19229851
references: Clin Biochem. 2002 Sep;35(6):471-5
references: 12413608
references: J Clin Oncol. 2005 Sep 1;23(25):6157-62
references: 16135482
references: J Clin Oncol. 2008 Feb 20;26(6):835-41
references: 18281654
references: Lancet. 1994 Dec 10;344(8937):1594-8
references: 7527116
references: Cancer. 2008 Jan 15;112(2):315-25
references: 18008359
references: Urology. 2006 Aug;68(2):342-7
references: 16904449
references: Prostate Cancer Prostatic Dis. 1997 Dec;1(2):90-96
references: 12496922
references: J Clin Oncol. 2004 May 1;22(9):1655-63
references: 15117988
references: Prostate. 2002 Nov 1;53(3):241-5
references: 12386925
references: JAMA. 2005 Jul 27;294(4):440-7
references: 16046650
references: Nat Clin Pract Oncol. 2006 Dec;3(12):658-67
references: 17139317
references: Cancer. 2007 Apr 15;109(8):1689-95
references: 17330856
references: J Clin Oncol. 2008 Mar 20;26(9):1526-31
references: 18349404
references: Urology. 2000 May;55(5):694-9
references: 10792083
references: Clin Cancer Res. 2008 Jun 15;14(12):3785-91
references: 18559597
references: J Natl Cancer Inst. 2006 Apr 19;98(8):529-34
references: 16622122
references: N Engl J Med. 2009 Mar 26;360(13):1320-8
references: 19297566
references: Am J Pathol. 2001 Dec;159(6):2159-65
references: 11733366
references: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references: 19474385
references: Cancer. 2008 Apr 15;112(8):1862-8
references: 18320601
references: Eur Urol. 2006 Feb;49(2):293-302
references: 16387412
references: Urology. 2003 Feb;61(2):274-6
references: 12597929
references: Urology. 1999 Jun;53(6):1169-74
references: 10367847
references: Cancer. 1998 Dec 15;83(12):2540-7
references: 9874461
references: Int J Cancer. 2007 Apr 1;120(7):1499-504
references: 17205511
references: J Urol. 2009 May;181(5):2071-5; discussion 2076
references: 19286205
references: Urology. 2004 Feb;63(2):309-13; discussion 313-5
references: 14972478
references: BMC Med. 2008 Jul 08;6:19
references: 18611265
references: Med Decis Making. 2006 Nov-Dec;26(6):565-74
references: 17099194
references: Future Oncol. 2007 Aug;3(4):449-61
references: 17661720
references: N Engl J Med. 2004 May 27;350(22):2239-46
references: 15163773
references: J Urol. 2004 Jun;171(6 Pt 1):2239-44
references: 15126794
references: J Urol. 2003 Nov;170(5):1792-7
references: 14532778
references: Int J Biol Markers. 2009 Apr-Jun;24(2):65-9
references: 19634108
references: Urology. 2000 Jun;55(6):791-5
references: 10840078
references: Cancer. 2008 Dec 1;113(11):3075-99
references: 18823041
references: Clin Cancer Res. 2004 Mar 15;10(6):1992-9
references: 15041717
references: J Urol. 2000 Jan;163(1):311-6
references: 10604382
references: BMC Med. 2008 Feb 15;6:6
references: 18279502
references: Curr Opin Urol. 2008 May;18(3):279-96
references: 18382238
references: J Natl Cancer Inst. 2011 Mar 16;103(6):462-9
references: 21350221
references: J Urol. 2007 Apr;177(4):1298-302; discussion 1301-2
references: 17382716
references: Urol Clin North Am. 1993 Nov;20(4):681-6
references: 7505976
references: Clin Cancer Res. 2004 Sep 1;10(17):5808-14
references: 15355910
references: Clin Chem. 2005 Aug;51(8):1342-51
references: 15961552
references: J Clin Oncol. 2007 Feb 1;25(4):431-6
references: 17264339
references: J Urol. 2002 Mar;167(3):1306-9
references: 11832719
references: BJU Int. 2008 Mar;101(6):675-83
references: 17941930
references: Int J Cancer. 2009 Feb 1;124(3):664-9
references: 19004009
references: Eur Urol. 2009 May;55(5):1124-33
references: 18585843
references: Trends Biotechnol. 2004 Aug;22(8):411-6
references: 15283986
references: J Clin Oncol. 2007 Jul 20;25(21):3076-81
references: 17634486
references: Urology. 1995 Apr;45(4):591-6
references: 7536366
references: JAMA. 2005 Jul 6;294(1):66-70
references: 15998892
references: Prostate. 2001 Oct 1;49(2):101-9
references: 11582588
references: J Urol. 1999 Sep;162(3 Pt 1):897-901
references: 10458404
references: Clin Cancer Res. 2000 Jul;6(7):2702-6
references: 10914713
references: Urology. 2004 May;63(5):905-10; discussion 910-1
references: 15134977
references: BMJ. 2010 Sep 14;341:c4521
references: 20843935
references: J Urol. 2003 Dec;170(6 Pt 1):2181-5
references: 14634374
references: Endocr Rev. 2001 Apr;22(2):184-204
references: 11294823
references: J Natl Cancer Inst. 2007 Apr 4;99(7):526-32
references: 17405997
references: Cancer Res. 1998 Oct 15;58(20):4640-5
references: 9788616
references: Am J Clin Pathol. 2008 Jun;129(6):952-8
references: 18480013
references: J Natl Cancer Inst. 2003 May 7;95(9):634-5
references: 12734304
references: Nat Clin Pract Urol. 2006 Aug;3(8):439-48
references: 16902520
references: J Natl Cancer Inst. 2006 Nov 1;98(21):1521-7
references: 17077354
references: J Urol. 1997 Jun;157(6):2183-90
references: 9146611
references: J Urol. 2007 Jan;177(1):107-12; discussion 112
references: 17162015
references: J Urol. 2004 Jun;171(6 Pt 1):2234-8
references: 15126793
references: J Urol. 1994 Oct;152(4):1163-7
references: 7520949
references: Clin Biochem. 2010 Jul;43(10-11):926-8
references: 20450900
references: J Clin Oncol. 2010 May 20;28(15):2493-8
references: 20421547
references: Urology. 1998 Sep;52(3):360-5
references: 9730444
references: Nat Med. 1995 Apr;1(4):282-4
references: 7585049
references: J Clin Oncol. 2009 Aug 1;27(22):3591-7
references: 19506163
references: Eur Urol. 2007 Dec;52(6):1601-9
references: 17919807
references: JAMA. 1997 May 14;277(18):1452-5
references: 9145717
references: Urology. 1998 Jan;51(1):57-62
references: 9457289
references: J Natl Cancer Inst. 2006 Aug 16;98(16):1128-33
references: 16912265
references: J Biol Chem. 1992 Sep 25;267(27):19027-30
references: 1326540
references: Eur Urol. 2006 Mar;49(3):460-5; discussion 465
references: 16442212
references: Prostate. 2009 Feb 1;69(2):198-207
references: 18942119
references: Hum Pathol. 1993 Jan;24(1):4-9
references: 7678092
references: Prostate Cancer Prostatic Dis. 2008;11(2):112-20
references: 17998918
references: Int J Cancer. 2007 Nov 15;121(10):2212-7
references: 17657743
references: Eur Urol. 2008 Mar;53(3):468-77
references: 17997011
references: Urology. 2001 Dec;58(6):1008-15
references: 11744478
references: Urology. 2001 Sep;58(3):411-6
references: 11549490
references: Cancer. 2001 Dec 15;92(12):2985-92
references: 11753975
references: Clin Cancer Res. 2008 Mar 1;14(5):1418-22
references: 18316564
references: Clin Cancer Res. 2008 Jun 1;14(11):3362-6
references: 18519764
references: Prostate. 1999 May;39(2):123-9
references: 10221568
references: Eur Urol. 2007 Oct;52(4):1044-50
references: 17197071
references: Urology. 2009 Oct;74(4):873-7
references: 19476981
references: Int J Med Inform. 2003 Apr;70(1):41-8
references: 12706181
references: J Urol. 1998 Jan;159(1):5-12
references: 9400426
references: Nat Rev Cancer. 2008 Apr;8(4):268-78
references: 18337732
references: Clin Cancer Res. 2009 Dec 1;15(23):7316-21
references: 19934305
references: N Engl J Med. 2004 Jul 8;351(2):125-35
references: 15247353
references: J Clin Oncol. 2007 Aug 20;25(24):3582-8
references: 17704405
references: Cancer Res. 1992 Jun 15;52(12):3323-8
references: 1375867
references: Br J Cancer. 2004 Jun 14;90(12):2312-6
references: 15150588
references: Urology. 2000 Aug 1;56(2):255-60
references: 10925089
references: Clin Chem. 2006 Jan;52(1):59-64
references: 16391327
references: Prostate Suppl. 1996;7:3-16
references: 8950358
references: Urology. 2000 Jan;55(1):41-5
references: 10654892
references: JAMA. 1995 Jan 25;273(4):289-94
references: 7529341
references: J Clin Oncol. 2000 Mar;18(5):1036-42
references: 10694554
references: JAMA. 1992 Apr 22-29;267(16):2215-20
references: 1372942
references: Clin Cancer Res. 2010 Jun 15;16(12):3232-9
references: 20400522
references: J Clin Oncol. 2003 Apr 1;21(7):1223-31
references: 12663708
references: Eur Urol. 2008 Jul;54(1):8-10
references: 18262336
references: Nat Clin Pract Urol. 2005 Apr;2(4):183-90
references: 16474761
references: J Clin Oncol. 2001 Jun 1;19(11):2856-64
references: 11387358
references: J Clin Oncol. 2007 Feb 1;25(4):349-55
references: 17264329
references: Rev Urol. 2004 Spring;6(2):58-72
references: 16985579
references: Int J Cancer. 2011 May 15;128(10):2373-81
references: 20658531
references: J Urol. 1988 Dec;140(6):1466-9
references: 3193516
references: Recent Results Cancer Res. 2003;163:72-84; discussion 264-6
references: 12903844
references: Cancer Res. 2001 Sep 15;61(18):6958-63
references: 11559576
references: J Clin Oncol. 2003 Oct 1;21(19):3573-9
references: 12913106
references: Br J Cancer. 2010 Aug 24;103(5):708-14
references: 20664589
references: Urology. 2007 Jun;69(6):1143-6
references: 17572203
references: Prostate. 2005 Nov 1;65(3):216-21
references: 15948137
references: Prostate. 2002 Jun 1;51(4):268-75
references: 11987155